期刊文献+

心脏手术患者围术期肝素诱导的血小板减少症 被引量:8

Heparin-induced thrombocytopenia in patients undergoing cardiac surgery
下载PDF
导出
摘要 目的:了解心脏手术患者围术期肝素诱导的血小板减少症(heparin-induced thrombocytopenia,HIT)发生率及其抗体阳性率,探索HIT发病及其抗体产生的影响因素。方法:检测连续的315例心脏手术病例手术前后血小板计数、HIT抗体、血小板因子4(platelet factor 4,PF4)。按4Ts评分诊断HIT。按性别、年龄、病种等分别统计发生率及其抗体阳性率并分析影响因素。结果:HIT发生率3.5%(11/315),HIT抗体阳性率36.5%(115/315)。其中冠心病患者HIT发生率(17.1%)高于心脏瓣膜病患者(1.9%,P<0.05)和先天性心脏病患者(0.8%,P<0.05)。先天性心脏病患者HIT抗体阳性率(51.7%)高于心脏瓣膜病患者(30.5%,P<0.05),心脏瓣膜病患者HIT抗体阳性率高于冠心病患者(14.6%,P<0.05)。HIT患者术后严重并发症发生率(36.4%)高于非HIT患者(10.5%,P<0.05)。Logistic回归示HIT发病的影响因素为年龄,HIT抗体产生的影响因素有年龄和体外循环。结论:心脏手术患者围术期HIT发生率较低,但易产生严重并发症,致残致死率高,应警惕HIT发病的危险因素。 Objective: To investigate the incidence for heparin-induced thrombocytopenia(HIT) in patients undergoing cardiac surgery and to evaluate the risk factors for the generation of HIT-antibody. Methods: A total of 315 patients undergoing cardiac surgery in the Department of Cardiothoracic Surgery, Xiangya Hospital between December, 2013 and July, 2014 were enrolled for this study. Among them, 120, 154 and 41 were for surgery of congenital heart defect, valve and coronary artery bypass graft, respectively. There were 170 male patients and 69 patients were under 18 years old. Platelet counts, HIT-antibody and concentration of platelet factor 4(PF4) were tested before and after the surgery. Diagnosis of HIT was based on '4Ts'(Pretest Clinical Scoring System). Results: HIT was diagnosed in 11 patients(3.5%, 11/315). And thromboembolic events occurred in 2 of 11 patients with HIT. The positive ratio for HIT-antibody was 36.5%(115/315). The coronary artery disease patients had a higher incidence of HIT than that of either the valve disease or the congenital heart defect(17.1%, 7/41 versus 1.9%, 3/154 or 0.8%, 1/120; P<0.05). The congenital heart defect patients had a higher positive ratio for HIT-antibody than that of both the valve disease and the coronary artery disease. The valve disease patients had a higher positive ratio for HIT-antibody than that of the coronary artery disease(51.7%, 62/120 versus 30.5%, 47/154 versus 14.6%, 6/41; P<0.05). Major postoperative complications occurred more frequently in HIT patients(36.4%, 4/11 versus 10.5%, 32/304; P<0.05). Age was a risk factor for HIT(P=0.030, OR=1.083, 95%CI 1.008-1.163). Cardiopulmonary bypass(CPB)(P=0.037, OR=3.113, 95%CI 1.071–9.050) and age(P<0.001, OR=0.970, 95% CI 0.959–0.982) were risk factors for HITantibody. Conclusion: The incidence of HIT is low during cardiac surgery, but HIT is a highly risk factor for the major postoperative complications. More attentions should be paid to these severe complications and the risk factors for HIT.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2015年第7期790-796,共7页 Journal of Central South University :Medical Science
基金 中南大学湘雅医院临床科研基金(2013L06)~~
关键词 心脏手术 肝素诱导的血小板减少症 血小板因子4 危险因素 并发症 cardiac surgery heparin-induced thrombocytopenia platelet factor 4 risk factors complications
  • 相关文献

参考文献18

  • 1于淼.低分子肝素诱导的血小板减少症发病率及相关因素分析[D].河北医科大学2010
  • 2Matthew Seigerman,Paul Cavallaro,Shinobu Itagaki,Insung Chung,Joanna Chikwe.Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Cardiac Surgery in North America: An Analysis of the Nationwide Inpatient Sample[J]. Journal of Cardiothoracic and Vascular Anesthesia . 2014 (1)
  • 3Ruidong Zhang,Yue Huang,Mazhong Zhang,Jie Bai,Jinfen Liu.Serum Antibodies to the Heparin/Platelet Factor 4 Complex Are an Independent Predictor of Thrombotic Complications Following Pediatric Fontan Surgery[J]. Clinical and Applied Thrombosis/Hemostasis . 2012 (5)
  • 4John G Kelton,Marcie J Hursting,Nancy Heddle,Bruce E Lewis.Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition[J]. Blood Coagulation & Fibrinolysis . 2008 (6)
  • 5Faraz Kerendi,Vinod H. Thourani,John D. Puskas,Patrick D. Kilgo,Michael Osgood,Robert A. Guyton,Omar M. Lattouf.Impact of Heparin-Induced Thrombocytopenia on Postoperative Outcomes After Cardiac Surgery[J]. The Annals of Thoracic Surgery . 2007 (5)
  • 6Ik-Kyung Jang,Marcie J. Hursting.When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia[J]. Circulation . 2005 (20)
  • 7Theodore E. Warkentin.Heparin-Induced Thrombocytopenia: Diagnosis and Management[J]. Circulation . 2004 (18)
  • 8Theodore E Warkentin,Andreas Greinacher.Heparin-induced thrombocytopenia and cardiac surgery[J]. The Annals of Thoracic Surgery . 2003 (6)
  • 9Jeffrey A Morgan,Aftab R Kherani,Deon W Vigilance,Faisal H Cheema,Nicholas J Colletti,David I Sahar,Kung-Ming Jan,David L Diuguid,Roman Nowygrod,Mehmet C Oz,Michael Argenziano.Off-pump right atrial thrombectomy for heparin-induced thrombocytopenia with thrombosis[J]. The Annals of Thoracic Surgery . 2003 (2)
  • 10Claire Pouplard,Marc-Antoine May,Sophie Iochmann,Jean Amiral,Anne-Marie Vissac,Michel Marchand,Yves Gruel.Antibodies to Platelet Factor 4-Heparin After Cardiopulmonary Bypass in Patients Anticoagulated With Unfractionated Heparin or a Low-Molecular-Weight Heparin: Clinical Implications for Heparin-Induced Thrombocytopenia[J]. Circulation . 1999 (19)

共引文献1

同被引文献74

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部